Bayer CEO: overhaul is leading to pharma pipeline boost - Reuters

Reuters | Sept. 22, 2025, 9:46 a.m. | Original
Bayer CEO: overhaul is leading to pharma pipeline boost Reuters
Bayer moves Parkinson's cell therapy into Phase III trial - Reuters Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price - Reuters